CLOs on the Move

KSQ Therapeutics

www.ksqtx.com

 
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed. The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates. KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ksqtx.com
  • 4 Maguire Road
    Lexington, MA USA 02421
  • Phone: 617.674.9150

Executives

Name Title Contact Details
Kimya Harris
Chief Legal and Administrative Officer Profile

Similar Companies

Management Resource Solutions

Management Resource Solutions is a Thousand Oaks, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Empower ABA

Empower ABA is a company that provides Applied Behavior Analysis (ABA) therapy services for children with Autism Spectrum Disorder (ASD). Their mission is to empower families by providing the most effective ABA services to ensure that learners with aut...

Pacific Ambulance

Pacific Ambulance is a Lake Forest, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Kite Pharma

Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.

Paramus Surgical Ctr

Paramus Surgical Ctr is a Paramus, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.